Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
11
NCT00267085
Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease
Phase: Phase 2
Role: Collaborator
Start: Dec 31, 2005
Completion: Jul 31, 2008